Phase II trial of irinotecan and cisplatin combination as first-line chemotherapy in patients with advanced esophageal squamous-cell carcinoma: An interim report

被引：1
|
作者：
Zhang, X.
Shen, L.
Li, J.
Li, Y.
Zhou, J.
Lu, Z.
Lu, M.
机构：
[1] Peking Univ, Canc Hosp & Inst, Dept Gastrointestinal Oncol, Beijing 100871, Peoples R China
[2] Peking Univ, Canc Hosp, Dept Gastrointestinal Oncol, Beijing 100871, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 04期
关键词：
D O I：
10.1200/jco.2011.29.4_suppl.137
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
137
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Phase II study of first-line biweekly docetaxel and cisplatin combination chemotherapy in advanced gastric cancer
    G. Quintero-Aldana
    M. Jorge
    C. Grande
    M. Salgado
    E. Gallardo
    S. Varela
    C. López
    M. J. Villanueva
    A. Fernández
    E. Alvarez
    P. González
    J. Castellanos
    J. Casal
    R. López
    B. Campos Balea
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 731 - 737
  • [42] A phase II trial of weekly irinotecan and cisplatin for chemotherapy-naive patients with metastatic or recurrent squamous cell carcinoma of the esophagus
    Lee, Dae Ho
    Han, Ji-Youn
    Yu, Sun Young
    Lim, Eun Ju
    Kim, Hyae Young
    Kim, Heung Tae
    Lee, Jin Soo
    Kim, Noe Kyeong
    ANNALS OF ONCOLOGY, 2006, 17 : 320 - 320
  • [43] A phase II study of S-1 and irinotecan combination chemotherapy in patients with advanced gastric cancer as a first-line therapy
    Ryoo, B. Y.
    Kang, H. J.
    Yang, S. H.
    Cho, S. H.
    Oh, S. J.
    Lee, M. H.
    Song, E. K.
    Chung, H. C.
    EJC SUPPLEMENTS, 2007, 5 (04): : 274 - 274
  • [44] A phase II trial of gefitinib in combination with capecitabine and oxaliplatin as first-line chemotherapy in patients with advanced colorectal cancer
    Gelibter, Alain J.
    Gamucci, Teresa
    Pollera, Camillo F.
    Di Costanzo, Francesco
    Nuzzo, Carmen
    Gabriele, Angela
    Signorelli, Carlo
    Gasperoni, Silvia
    Ferraresi, Virginia
    Giannarelli, Diana
    Cognetti, Francesco
    Zeuli, Massimo
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (09) : 2117 - 2123
  • [45] Erratum to: Phase II trial of biweekly docetaxel, cisplatin, and 5-fluorouracil chemotherapy for advanced esophageal squamous cell carcinoma
    Yoshihiro Tanaka
    Kazuhiro Yoshida
    Atsuko Yamada
    Toshiyuki Tanahashi
    Naoki Okumura
    Nobuhisa Matsuhashi
    Kazuya Yamaguchi
    Tatsuhiko Miyazaki
    Cancer Chemotherapy and Pharmacology, 2016, 77 : 1153 - 1155
  • [46] Combination of docetaxel, cisplatin, and capecitabine (DCX) as a first-line chemotherapy in patients with metastatic gastric carcinoma: A phase II study
    Narimanov, Mekhty
    Tryakin, Alexey
    Bazin, Igor
    Kanagavel, Dheepak
    Tjulandin, Sergei
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [47] The efficacy and toxicities of combined lobaplatin with paclitaxel as a first-line chemotherapy for advanced esophageal squamous cell carcinoma
    Chen, Ming-Qiu
    Chen, Cheng
    Lu, Hai-Jie
    Xu, Ben-Hua
    JOURNAL OF THORACIC DISEASE, 2015, 7 (10) : 1749 - 1755
  • [48] Prospective phase II trial of a combination of gemcitabine, cisplatin and UFT as first-line treatment in patients with advanced, unresectable, non-small cell lung carcinoma
    Jin, S. S.
    Min, Y.
    Kim, H.
    Ahn, J.
    Jegal, Y.
    Seo, K.
    Park, C.
    Shin, J.
    Cha, H.
    Kwon, W.
    Park, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [49] Nivolumab combination therapy as first-line treatments for unresectable, advanced or metastatic esophageal squamous cell carcinoma
    Rogers, Jane E.
    Yamashita, Kohei
    Sewastjanow-Silva, Matheus
    Rosa Vicentini, Ernesto
    Waters, Rebecca
    Ajani, Jaffer A.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (06) : 565 - 571
  • [50] Prospective phase II trial of a combination of gemcitabine, cisplatin and UFT as first-line treatment in patients with advanced, unresectable, non-small cell lung carcinoma
    Shin, S. J.
    Min, Y. J.
    Baek, J. H.
    Kim, H.
    Ann, J. J.
    Jegal, Y. J.
    Park, C. Y.
    Cha, H. J.
    Kwon, W. J.
    Park, J. H.
    EJC SUPPLEMENTS, 2007, 5 (04): : 381 - 381
12345